Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2022 / Articles / Oct / The Big Question: Can Pharma Truly Be Remodelled with AI?
Business & Regulation Digital Technologies Supply Chain Trends & Forecasts Small Molecules Technology and Equipment Business Practice Clinical Trials Translational Science Supply Chain Business & Trends Small Molecules Technology & Manufacturing Development & Clinical

The Big Question: Can Pharma Truly Be Remodelled with AI?

Join us as we explore the benefits and pitfalls of AI use in pharmaceutical contexts

By Maryam Mahdi 10/03/2022 2 min read

Share

Perhaps the pharmaceutical industry’s relationship with artificial intelligence will continue to grow from strength to strength – taking science to hitherto unimagined places. Perhaps algorithms and machine learning platforms will be slowly, subtly, but irreversibly integrated into the world of medicine making… 

We explore. Welcome to The Big Question – a new series for The Medicine Maker that takes an in-depth look at a hot topic. First up: artificial intelligence (AI). 

But why? AI is often touted in pharma circles as a great enabler that could streamline manufacturing processes, cut out the noise in the mountains of data produced and obtained by pharmaceutical companies, and reduce the risk of error. To this end, more and more companies are beginning to explore how they can implement AI technologies. 

Our experts had vastly different interpretations and thoughts on the topic. Can AI technologies really help drive the industry to new heights or does the hype outweigh reality? Let’s hear their views.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

About the Author(s)

Maryam Mahdi

After finishing my degree, I envisioned a career in science communications. However, life took an unexpected turn and I ended up teaching abroad. Though the experience was amazing and I learned a great deal from it, I jumped at the opportunity to work for Texere. I'm excited to see where this new journey takes me!

More Articles by Maryam Mahdi

False

Advertisement

Recommended

False

Related Content

The Next Decade of Cell and Gene Therapies
Advanced Medicine Bioprocessing - Upstream & Downstream Trends & Forecasts Digital Technologies
The Next Decade of Cell and Gene Therapies

May 7, 2025

5 min read

Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.

Partnership Cuts Cost of CAR T Manufacturing
Advanced Medicine Technology and Equipment Digital Technologies
Partnership Cuts Cost of CAR T Manufacturing

March 13, 2025

4 min read

Manufacturing bottlenecks remain a key hurdle in CAR-T therapy. Can automation and digital integration change that? Trenchant and Autolomous explore the possibilities.

Forecasting Medicine Use and Controlling Supply Chains
Digital Technologies Standards & Regulation Supply Chain
Forecasting Medicine Use and Controlling Supply Chains

March 19, 2025

3 min read

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.

AI, Big Data, and Digital Disruption
Digital Technologies Clinical Trials
AI, Big Data, and Digital Disruption

March 31, 2025

7 min read

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.